Difficulty: Medium
Average Score: 94%
Practice
Which of the following drugs does NOT cause enhanced activity of the GABA receptor?
Correct answer
B
Rationale
In the context of basic care for a paraplegic patient, understanding the pharmacology of drugs commonly used in anesthesia is essential. In this case, the correct answer is B) Ketamine. Ketamine is a dissociative anesthetic that primarily acts by antagonizing the NMDA receptor, resulting in its unique effects on perception and consciousness. Unlike other options, such as A) Etomidate, C) Propofol, and D) Midazolam, which enhance the activity of the GABA receptor, Ketamine does not directly affect the GABAergic system.
Etomidate, propofol, and midazolam are all known to enhance the activity of the GABA receptor, leading to their characteristic effects of sedation, amnesia, and anxiolysis. Understanding the specific mechanisms of action of these drugs is crucial for safe and effective patient care, particularly in managing pain, anxiety, and sedation in paraplegic patients undergoing procedures or surgeries.
Educationally, knowing the differences in how anesthetics interact with various neurotransmitter systems enables healthcare providers to make informed decisions when selecting the most appropriate medication for a given clinical scenario. This knowledge not only promotes patient safety but also facilitates optimal outcomes and patient comfort during procedures. By grasping the nuances of drug pharmacology, healthcare professionals can tailor treatment plans to individual patient needs, ensuring high-quality care in the management of paraplegic patients and beyond.
Etomidate, propofol, and midazolam are all known to enhance the activity of the GABA receptor, leading to their characteristic effects of sedation, amnesia, and anxiolysis. Understanding the specific mechanisms of action of these drugs is crucial for safe and effective patient care, particularly in managing pain, anxiety, and sedation in paraplegic patients undergoing procedures or surgeries.
Educationally, knowing the differences in how anesthetics interact with various neurotransmitter systems enables healthcare providers to make informed decisions when selecting the most appropriate medication for a given clinical scenario. This knowledge not only promotes patient safety but also facilitates optimal outcomes and patient comfort during procedures. By grasping the nuances of drug pharmacology, healthcare professionals can tailor treatment plans to individual patient needs, ensuring high-quality care in the management of paraplegic patients and beyond.